Last update:
Endocrinology news
Immune cells in the brain may tune fertility hormones, animal study suggests
The kick-off signal for puberty begins in the brain. Specifically, in the hypothalamus, where specific neurons release a hormone that activates the hypophysis, at the base of the skull, which then releases other hormones ...
2 hours ago
0
0
Father's tobacco use may raise children's diabetes risk, mouse study suggests
A mouse study found that a father's nicotine exposure can affect the offspring's ability to process sugar and may contribute to diabetes risk, according to new research published in the Journal of the Endocrine Society.
7 hours ago
0
0
Quantitative imaging of beta cell mass may help with treatment for type 1 diabetes
In type 1 diabetes, the immune system starts to destroy insulin-producing beta cells in the pancreas. Progressive loss of these cells destabilizes the body's glucose levels and drives the course of the disease, so preserving ...
15 hours ago
0
0
Study uncovers a new mechanism explaining how chemicals affect sex hormones
Researchers at the University of Oulu have identified a previously unknown mechanism in humans that may explain why certain medicines and environmental chemicals disrupt the balance of sex hormones. The finding deepens scientific ...
20 hours ago
0
0
Fructose-fed mice with low testosterone gained liver weight, but antibiotics blunted it
Low testosterone in itself can cause a variety of health problems, but the addition of a poor diet can exacerbate certain conditions. Metabolic dysfunction-associated steatotic liver disease (MASLD) is one example that approximately ...
23 hours ago
0
0
Study links higher asprosin to less weight gain after menopause
Researchers at the University of California, Irvine Joe C. Wen School of Population & Public Health have identified how the hormone asprosin influences long-term weight change among postmenopausal women in the United States. ...
Mar 11, 2026
0
0
GLP-1 medication changes may support long-term weight management
Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...
Mar 10, 2026
0
0
Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes ...
Mar 10, 2026
0
0
Circadian rhythm drives metabolic dysfunction in fat cells, study finds
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have discovered how disruptions in ...
Mar 9, 2026
0
1
Elevated heart failure risk identified in adults with prediabetes, hypertension and subclinical heart injury or stress
A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress—heart muscle damage without symptoms of a heart attack—are ...
Mar 9, 2026
0
0
Heart and metabolic risk factors more strongly linked to liver fibrosis in women than men, study finds
Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors. The study, just published in ...
Mar 9, 2026
0
0
AI model enables personalized blood glucose predictions for type one diabetes
Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a result, patients with T1D must closely monitor their blood glucose (BG) levels and rely on insulin ...
Mar 9, 2026
0
0
High-intensity interval training boosts muscle mitochondria, study shows
Researchers from the University of Southern Denmark investigated how eight weeks of high-intensity interval training affect the structure of mitochondria—the parts of muscle cells that produce energy. The study shows that ...
Mar 9, 2026
0
0
Study finds iron deficiency can halt young pancreatic beta cell growth
The beta cells in our pancreas act as highly sensitive sensors that constantly measure the amount of sugar in our blood. As soon as we eat something and the sugar level rises, the beta cells produce insulin to help the body ...
Mar 8, 2026
0
0
How do GLP-1 agonists affect gene expression?
GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve cardiovascular health. ...
Mar 6, 2026
0
1
Anti-obesity treatment could cost as little as $3 per month: Study
A blockbuster anti-obesity and diabetes drug could cost as little as $3 per month to manufacture once it goes off patent later this month, researchers said Friday, providing a major opportunity to boost health in low- and ...
Mar 6, 2026
0
1
Some patients keep weight off with fewer GLP-1 injections, study finds
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, according to a small new study.
Mar 6, 2026
0
1
AAOS: GLP-1 receptor agonist use increases five-year risk for osteoporosis
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared ...
Mar 6, 2026
0
0
Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity
A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, ...
Mar 5, 2026
0
1
What to know about how GLP-1 medications might fight addiction
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders—and reduce the tragic outcomes they cause, a large new study finds.
Mar 5, 2026
0
0
Study maps US diabetes–cancer hotspots
A new University of Kentucky study has mapped areas across the U.S. where high rates of diabetes and deaths from diabetes-related cancers overlap. The UK Markey Cancer Center and Barnstable Brown Diabetes Center research ...
Mar 5, 2026
0
0
GLP‑1 drugs like Ozempic may lower the risk of addiction: New study
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.
Mar 5, 2026
0
0
GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn't use a patch. He didn't set a quit date. ...
Mar 5, 2026
0
0
Research reveals challenges of living with gestational diabetes
A study from the University of Limerick in Ireland has identified the hidden challenges of women living with and managing Gestational Diabetes Mellitus (GDM). The research led by academics in UL's Department of Psychology ...
Mar 5, 2026
0
0
How gut bacteria and diet can reprogram fat to burn more energy
Scientists at City of Hope and the Broad Institute and Keio University have discovered how specific gut bacteria work together with the diet to flip a metabolic switch—transforming energy-storing white fat into calorie-burning ...
Mar 4, 2026
0
0
